Novartis Sees Sales Growth Through 2031

Novartis Sees Sales Growth Through 2031

来源:WSJ发布于 2026-11-19

The drugmaker expects annual sales growth of 5% from 2026 to 2031, from a previous forecast of 5% to 6% over the 2025-30 period.

相关标的:NVS

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。